Press Releases


  • May 20, 2006.  BioTHER's first patent is issued in the USA.

  

  • October 19, 2006.   BioTHER is featured in VentureWire Life Sciences and VentureWire Professsionals.

 

  • December 2, 2006.  BioTHER's patent is issued in Singapore.

 

  • Jan 15, 2007.  Dr. Roussel is guest speaker at the PharmaEdge Summit, a Marcusevans International 3-day conference at Chateau Elan, Atlanta, GA on January 28, 2007.  He lectures on protein therapeutic for treatment of solid tumors.

 

  • April 15, 2007.   Dr. Roussel is guest speaker for the opening talk at the Evolution Summit, a Marcusevans International 3-day conference on pharma and biopharma business and trends at The Homestead, Hot Springs, VA on April 29, 2007.  His lecture topic is "New Trend in Protein Therapeutic - Complex Biopharmaceutical Composition".

 

  • July 25, 2007.  BioTHER's patent is issued in Europe.

 

  • March 2008.  Cofounder Dr. Gingras obtains a grant from the R. Macdonald Foundation to conduct preclinical data to test T1-IR efficacy at regressing solid tumors.

 

  • September 2010.  BioTHER first publication of data showing efficacy of T1-IR  to eliminate syngeneic tumors in mice.
 

 
  Site Map